Enhanced antitumor efficacy of sulfasalazine and mesalazine in colorectal cancer through modulatory action of Lacticaseibacillus rhamnosus GG
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-026-05523-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Rana Karam Elmahdy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Damanhour University, Damanhour, 22514, Egypt. Hauptthemen laut MEDLINE: Sulfasalazine, Lacticaseibacillus rhamnosus, Mesalamine, Colorectal Neoplasms. Die Arbeit nennt 127 Literaturangaben.
Abstract (Originalsprache)
Colorectal cancer (CRC) ranks as the second most lethal cancer worldwide. Probiotics have long been utilized to treat gastrointestinal diseases. Probiotics may play a role in the prevention and treatment of CRC. Additionally, the anti-inflammatory drugs sulfasalazine (SSA) and mesalazine (MESA) have a preventive role in CRC. This study investigates the modulatory antitumor effects of combining the probiotic Lacticaseibacillus rhamnosus GG (LGG) with SSA or MESA and the associated molecular mechanisms in CRC. In vitro studies of LGG-CFS, both alone and in combination with SSA or MESA, were assessed in HCT-116 and HT-29 CRC cells. In vivo, 61 albino rats aged 8 weeks were used and CRC was induced using 1,2-dimethylhydrazine. The 1,2-dimethylhydrazine-induced rats were divided into six groups, each of eight-in addition to the negative control group (received phosphate buffer saline only)-as follows: (I) positive control group (received DMH only), (II) SSA-treated group, (III) MESA-treated group, (IV) LGG-treated group, (V) SSA + LGG-treated group, and (VI) MESA + LGG-treated group. Rats received daily oral doses of SSA (250 mg/kg), MESA (62.5 mg/kg), LGG (1 × 109 CFU lactobacilli/1 ml), SSA + LGG, and MESA + LGG for 4 weeks. In both cell lines, the control group (positive control, human cancerous cells without further treatment) exhibited a reduction in annexin V, whereas the specified treatments elevated annexin V levels in both cells, thereby inducing apoptosis. In vivo, positive control rats exhibited upregulation of TLR2/AKT/NF-κB, IL-6, IFN-γ/STAT-3/PD-L1, COX-2/HIF-1α/VEGF signaling, and Ki-67, resulting in the induction of proliferation, hypoxia, and angiogenesis and inhibition of apoptosis. All treatment regimens downregulated TLR2/AKT/NF-κB, IL-6, IFN-γ/STAT-3/PD-L1, COX-2/HIF-1α/VEGF crosstalk's, and Ki-67, hence inhibiting proliferation, hypoxia, angiogenesis, and inducing apoptosis. Surprisingly, the combination of LGG with either SSA or MESA demonstrated the greatest efficacy through the aforementioned pathways with the superiority to the LGG + SSA combination in both experimental models. The current findings revealed novel insights into the potential antitumor effects of combining LGG with either SSA or MESA compared to each drug individually in CRC management. Further preclinical and clinical trials are warranted to evaluate this promising regimen compared to standard therapy of CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Damanhour University, Damanhour, 22514, Egypt.
- Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy and Drug Manufacturing, Pharos University in Alexandria, Alexandria, Egypt.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Damanhour University, Damanhour, 22514, Egypt. maged.helmy@pharm.dmu.edu.eg.
- Pharmacology and Toxicology Department, Faculty of Pharmacy, Damanhour National University, El-Bahira, Egypt. maged.helmy@pharm.dmu.edu.eg.
Zitieren
APA
Elmahdy, R. K., Abdel-Raheem, I. T., Abd-Alhaseeb, M. M., Ghoneim, A. I., & Helmy, M. W. (2026). Enhanced antitumor efficacy of sulfasalazine and mesalazine in colorectal cancer through modulatory action of Lacticaseibacillus rhamnosus GG. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05523-2
Vancouver
Elmahdy RK, Abdel-Raheem IT, Abd-Alhaseeb MM, Ghoneim AI, Helmy MW. Enhanced antitumor efficacy of sulfasalazine and mesalazine in colorectal cancer through modulatory action of Lacticaseibacillus rhamnosus GG. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05523-2
BibTeX
@article{Elmahdy2026,
author = {Elmahdy, Rana Karam and Abdel-Raheem, Ihab Talaat and Abd-Alhaseeb, Mohammad Mahmoud and Ghoneim, Asser Ibrahim and Helmy, Maged Wasfy},
title = {Enhanced antitumor efficacy of sulfasalazine and mesalazine in colorectal cancer through modulatory action of Lacticaseibacillus rhamnosus GG},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-05523-2}
}
EUVIMED